0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Programmed Cell Death Protein"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
China Bispecific Antibodies Market and Clinical Pipeline Insight 2028 - Product Thumbnail Image

China Bispecific Antibodies Market and Clinical Pipeline Insight 2028

  • Drug Pipelines
  • August 2023
  • 400 Pages
  • China
From
EUR$3,000USDGBP
From
EUR$3,900USDGBP
From
EUR$9,000USDGBP
From
EUR$3,300USDGBP
From
EUR$2,625USDGBP
EUR$5,250USDGBP
From
EUR$4,200USDGBP
Checkpoint Inhibitors Global Market Report 2024 - Product Thumbnail Image

Checkpoint Inhibitors Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
EUR$5,000USDGBP
From
EUR$2,600USDGBP
TIM-3 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

TIM-3 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Checkpoint Inhibitors - Competitive landscape, 2023 - Product Thumbnail Image

Checkpoint Inhibitors - Competitive landscape, 2023

  • Report
  • April 2023
  • 350 Pages
  • Global
From
EUR$3,250USDGBP
From
EUR$3,950USDGBP
ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030

  • Report
  • February 2021
  • 50 Pages
  • Global
From
EUR$3,250USDGBP
From
EUR$7,950USDGBP
Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
EUR$2,500USDGBP
Oncolytic Virus Cancer Therapy - Pipeline Insight, 2024 - Product Thumbnail Image

Oncolytic Virus Cancer Therapy - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 280 Pages
  • Global
From
EUR$5,000USDGBP
LAG-3 Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

LAG-3 Antagonist - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Loading Indicator

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body. PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more